Factor VIII immunogenicity
- PMID: 9873793
- DOI: 10.1046/j.1365-2516.1998.440552.x
Factor VIII immunogenicity
Abstract
The immunogenicity of factor VIII depends on the interaction of multiple parametres including host susceptibility and characteristics of the factor VIII preparations. We briefly review here the basic mechanisms by which tolerance to self is established, maintained, and possibly broken in the context of haemophilia A, with special emphasis on the severity of the disease. Reference is also made to the situation observed in healthy individuals and patients with autoantibodies to factor VIII.
Similar articles
-
Immunogenicity and immune tolerance coagulation Factors VIII and IX.Dev Biol (Basel). 2003;112:55-9. Dev Biol (Basel). 2003. PMID: 12762504
-
Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.Haematologica. 2000 Oct;85(10 Suppl):113-6. Haematologica. 2000. PMID: 11187862 Review.
-
[Origin and nature of the neutralizing immune response against therapeutic factor VIII].Med Sci (Paris). 2020 Apr;36(4):341-347. doi: 10.1051/medsci/2020060. Epub 2020 May 1. Med Sci (Paris). 2020. PMID: 32356710 Review. French.
-
Induction of immune tolerance with factor VIII concentrate in patients with hemophilia A and inhibitors.Prog Clin Biol Res. 1990;324:59-68. Prog Clin Biol Res. 1990. PMID: 2106693 Review. No abstract available.
-
Induction of tolerance using porcine factor VIII.Vox Sang. 1996;70 Suppl 1:68-9. Vox Sang. 1996. PMID: 8869473 No abstract available.
Cited by
-
Immunogenicity and pharmacokinetic studies of recombinant factor VIII containing lipid cochleates.Drug Deliv. 2011 May;18(4):246-54. doi: 10.3109/10717544.2010.536269. Epub 2010 Nov 30. Drug Deliv. 2011. PMID: 21114461 Free PMC article.
-
Soy Phosphatidylinositol-Containing Lipid Nanoparticle Prolongs the Plasma Survival and Hemostatic Efficacy of B-domain-Deleted Recombinant Canine Factor VIII in Hemophilia A Dogs.J Pharm Sci. 2016 Aug;105(8):2459-64. doi: 10.1016/j.xphs.2016.05.023. Epub 2016 Jun 30. J Pharm Sci. 2016. PMID: 27372547 Free PMC article.
-
Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice.AAPS J. 2010 Sep;12(3):473-81. doi: 10.1208/s12248-010-9207-z. Epub 2010 Jun 2. AAPS J. 2010. PMID: 20517659 Free PMC article.
-
Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins.BioDrugs. 2021 Mar;35(2):125-146. doi: 10.1007/s40259-020-00465-4. Epub 2021 Feb 1. BioDrugs. 2021. PMID: 33523413 Free PMC article. Review.
-
Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice.J Pharm Sci. 2006 Feb;95(2):358-71. doi: 10.1002/jps.20529. J Pharm Sci. 2006. PMID: 16372314 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical